Case report: Interstitial pneumonitis from treatment with gemcitabine

Hospital Pharmacy

Volumn 49, Issue 9, 2014, Pages 847-850

  Poole, Brolin ^a   Hamilton, Leslie ^b   Brockman, Megan ^a   Byrd, Debbie ^b  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

Author keywords

gemcitabine; pneumonitis; pulmonary toxicity

Indexed keywords

AMIODARONE; GEMCITABINE; GLUCOSE; LEVOTHYROXINE; LISINOPRIL; LORAZEPAM; LOSARTAN; MECLOZINE; METFORMIN; METOPROLOL TARTRATE; OMEPRAZOLE; PREDNISONE; PROCHLORPERAZINE;

AGED; APPENDECTOMY; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOMEGALY; CASE REPORT; CHOLECYSTECTOMY; COUGHING; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFECTION; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG EDEMA; LUNG FUNCTION; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN SATURATION; OXYGEN THERAPY; PANCREAS CANCER; PANCREAS RESECTION; PATIENT HISTORY OF SURGERY; PLEURA EFFUSION; PRESCRIPTION; SLEEP DISORDERED BREATHING; SPLENECTOMY; STEROID THERAPY; THORAX RADIOGRAPHY; TREATMENT DURATION;

EID: 84914162597     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4909-847     Document Type: Article

References (15)

1. Aapro MS, Martin C, Hatty S. Gemcitabine-A safety review. Anticancer Drugs. 1998; 9(3):191-201.
2. Umemura S, Yamane H, Suwaki T et al. Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer. J Cancer Res Clin Oncol. 2011;137(10):1469-1475.
3. Limper AH. Chemotherapy-induced lung disease. Clin Chest Med. 2004;25:53-64.
4. Gupta N, Ahmed I, Steinberg H et al. Gemcitabineinduced pulmonary toxicity: Case report and review of the literature. Am J Clin Oncol. 2002;25:96-100.
5. Matsumura E, Ashikari A, Tasaki S. Case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer. Acta Urologica Japonica. 2011;57(2):81-85.
6. Shaib W, Lansigan F, Cornfeld D, et al. Gemcitabineinduced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. J Pancreas. 2008;9(6):708-714.
7. Ko E, Lee S, Goodman A. Gemcitabine pulmonary toxicity in ovarian cancer. Oncologist. 2008;13(7):807-811.
8. Connolly S, Cairns J, Gent M, et al. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-Analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet. 1997;350:1417-1424.
9. The CASCADE Investigators. Cardiac arrest in Seattle: Conventional versus amiodarone drug evaluation (the CASCADE study). Am J Cardiol. 1991;67:578-558.
10. Ernawati DK, Stafford L, Hughes J. Amiodarone-induced pulmonary toxicity. Br J Clin Pharmacol. 2008;66(1):82-87.
11. Wood DL, Osborn MJ, Rooke J, et al. Amiodarone pulmonary toxicity: Report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc. 1985;60:601-603.
12. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation. 1990;82(1):51-59.
13. Fabiani I, Tacconi D, Grotti S, et al. Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema. J Cardiovasc Med (Hagerstown). 2011:12(5);361-365.
14. Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest. 1988;93:1067.
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.